MetaCap

Lantern Pharma (LTRN) vs NuCana (NCNA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Lantern Pharma is the larger company by market cap ($3.9 million vs $3.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LTRN-73.08%NCNA-34.25%
+4%-37%-77%
Oct 7, 20261 yearNov 20, 2026
LTRN-69.85%NCNA-31.86%
+3%-35%-73%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LTRN versus NCNA key metrics
MetricLTRNNCNA
Share price$0.245$0.7495
Market cap$3.89M$3.61M
1-day change-13.73%+4.39%
YTD return-91.91%—
1-year return-91.89%—
5-year return-97.27%—
EPS (TTM)$-1.44$0.00
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-17.12M—
52-week high$4.34$4.55
52-week low$0.2286$0.62
Distance from 52-week high-94.35%-83.53%
Analyst consensusnone—
Avg. price target upside+7042.86%—
Average volume249.66K118.13K
Shares outstanding15.89M4.82M
Employees1610
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Lantern Pharma

LTRN stock →

Lantern Pharma Inc. focuses on the discovery and development of oncology drug in India.

Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees

About NuCana

NCNA stock →

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines.

Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees

LTRN vs NCNA FAQ

Which is bigger, Lantern Pharma or NuCana?

Lantern Pharma (LTRN) is larger, with a market capitalization of $3.89M compared with $3.61M for NuCana (NCNA).

Are Lantern Pharma and NuCana in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons